Assistant Professor of Medicine, Massachusetts General Hospital
Oncology
Dr. Eyal C. Attar, MD
|
|
Give Review
Dr. Eyal C. Attar works in the field of Oncology. He went to medical school at University of North Carolina at Chapel Hill School of Medicine. University of North Carolina at Chapel Hill School of Medicine is a one of the best medicals schools. University of North Carolina at Chapel Hill School of Medicine is ranked 22 in research and 2 in primary care medicine He over the years received 1 awards: "Regional Top Doctor". Eyal C. Attar has written publications. He has 36 publications published with PubMed. The lastest publication is: 'New Insights in AML Biology From Genomic Analysis.' He is registered with Medicare and accepts Medicare payments.
Publications
- New Insights in AML Biology From Genomic Analysis.
- Presentation and outcomes among patients with isolated Myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis.
- Population-based disparities in survival among patients with core-binding factor Acute myeloid leukemia: A SEER database analysis.
- Engraftment Syndrome after allogeneic hematopoietic cell transplantation in adults.
- Phase I Study of Urate Oxidase in the Reduction of Acute Graft-vs-Host Disease Following Myeloablative Allogeneic Stem Cell Transplantation.
- Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk Acute promyelocytic leukaemia may eliminate the need for maintenance...
- Differential regulation of myeloid Leukemias by the bone marrow microenvironment.
- Acute Myeloid Leukemia, Version 2.2013.
- Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and Acute myeloid leukemia (AML).
- Risk factors for invasive fungal Disease after allogeneic hematopoietic stem cell transplantation: a single center experience.
- Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for Myelodysplastic Syndrome or Acute Myeloid Leukemia.
- Association between baseline body mass index (BMI) and overall survival among patients over age 60 with Acute myeloid leukemia (AML).
- Bortezomib Added to Daunorubicin and Cytarabine During Induction Therapy and to Intermediate-Dose Cytarabine for Consolidation in Patients With Previously Untreated Ac...
- Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed Acute myeloid leukemia, to assess disease activity and therapeutic response.
- Expression of ñ4ò7 integrin on memory CD8(+) T cells at the presentation of Acute intestinal GVHD.
- The expanding frontier of hematopoietic Cell transplantation.
- Phase II Trial of Parathyroid Hormone following Double Umbilical Cord Blood Transplantation.
- Bilateral ear swelling and erythema after chemotherapy: a case of ara-C ears.
- Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms.
- Get out--and stay out.
- AKT/FOXO signaling enforces reversible differentiation blockade in myeloid Leukemias.
- Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal Acute myeloid leukemia (CN-AML) and FLT3ITD.
- Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutations.
- High-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin Lymphoma.
- Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
- Case records of the Massachusetts General Hospital. Case 27-2010. A 73-year-old woman with chronic Anemia.
- Case records of the Massachusetts General Hospital. Case 23-2010. A 49-year-old man with erythrocytosis, perinephric fluid collections, and renal failure.
- Donor-derived second hematologic malignancies after cord blood transplantation.
- Autopsy diagnosis of progressive multifocal leukoencephalopathy with JC virus-negative CSF after cord blood stem-Cell transplantation.
- Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with Acute myelogenous leukemia.
- Case records of the Massachusetts General Hospital. Case 33-2007. A 49-year-old HIV-positive man with Anemia.
- Case records of the Massachusetts General Hospital. Case 14-2006. A 25-year-old woman with Anemia and iron overload.
- Flowing Cells through pulsed electric fields efficiently purges stem Cell preparations of contaminating myeloma Cells while preserving stem Cell function.
- P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem Cells.
- Putative RNA-splicing gene LUC7L2 on 7q34 represents a candidate gene in pathogenesis of Myeloid malignancies.
Schools
University Of North Carolina Chapel Hill School Of Medicine
Brigham and Womens Hospital
Dana Farber Cancer Institute
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Acute Lymphocytic Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Brigham and Women's Hospital -
University of North Carolina at Chapel Hill School of Medicine
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1407847965 | |
| NPPES Provider LastName | ATTAR | |
| NPPES Provider FirstName | EYAL | |
| NPPES Provider ZIPCode | 021142621 | |
| NPPES Provider State | MA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 229.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1407847965 |
| Last Name Of The Provider | ATTAR |
| First Name Of The Provider | EYAL |
| View All |
Similar Doctors
|
|
Dr. Juan C. Vera, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew G. Oser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anita Kumar, MD |
|
|
Dr. Paul E. Goss, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jane C. Weeks, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Stephen M. Rothenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deepa Rangachari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas A. Abrams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lecia V. Sequist, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Noopur S. Raje, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|